Recent Advances in Synthesis of PAR Ligands as Therapeutic Strategy for Inflammatory Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|9|6|653-663

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.6, 2009-06, pp. : 653-663

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Helminth Products as a Potential Therapeutic Strategy for Inflammatory Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 2, 2008-06 ,pp. : 113-118

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in feeding suppressing agents: potential therapeutic strategy for the treatment of obesity

By Nakazato Atsuro   Chaki Shigeyuki  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1677-1692

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 27, 2017-11 ,pp. : 3000-3016

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting of Th1-Associated Chemokine Receptors CXCR3 and CCR5 as Therapeutic Strategy for Inflammatory Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1089-1096

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B as a Therapeutic Target for Transcription Factor Decoy Strategy in Inflammatory Diseases

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 1, 2003-03 ,pp. : 51-56

Bentham Science Publishers

Access to resources Recommend Favorite